Search for: "RANBAXY INC" Results 21 - 40 of 91
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Aug 2007, 5:13 pm
Ranbaxy Inc. et al.3:07-cv-03755; filed August 9, 2007 in the District of Court... [read post]
24 Dec 2008, 9:04 am
Earlier, Schering and Sepracor have similar settlement agreements with generic manufacturers including Ranbaxy, Perrigo Co. and Watson Pharmaceuticals Inc. [read post]
30 Sep 2013, 8:12 am by Gene Quinn
District Court for the District of Delaware against Apotex Corp.; Hetero USA Inc.; Lupin Ltd.; Mylan Pharmaceuticals, Inc.; Par Pharmaceuticals, Inc.; Ranbaxy Laboratories Ltd.; and related companies and subsidiaries. [read post]
16 Jul 2010, 7:14 am by The Docket Navigator
Ranbaxy Laboratories Inc., 2-10-cv-00121 (TXED July 14, 2010, Report & Recommendations) (Everingham, M.J.) [read post]
23 Oct 2013, 4:17 am by Ben Vernia
On October 23, the long-term care pharmacy giant Omnicare, Inc., filed an 8-K statement with the SEC disclosing that it had reached an agreement in principle to settle allegations of kickbacks raised by a qui tam relator in the Northern District of Ohio, for $120 million. [read post]
3 Mar 2012, 9:45 am by Lawrence B. Ebert
In an article titled Sector Snap: Generic competition and biotech drugs , one notes the irony that generic maker Teva is facing Hatch-Waxman challenges from Mylan Inc. and Novartis AG over its patented drug Copaxone, a drug for treatment of multiple sclerosis. [read post]
13 Sep 2013, 7:43 am
The largest settlement this year involved Ranbaxy, Inc., based in Princeton New Jersey. [read post]
12 Jul 2013, 11:00 am
More Than $34 Million to Resolve False Claims Act Allegations Related to Kyphoplasty, Justice.gov, July 2, 2013 Medtronic Spine, Formerly Kyphon Inc., to Pay U.S. $75 Million to Resolve Allegations of Defrauding Medicare, Justice.gov, May 22, 2008 More Blog Posts:Nursing Home to Pay $2.7M for Medicaid Fraud Claims Brought to Light By Whistleblower, Boston Injury Lawyer Blog, March 23, 2013 Whistleblower Lawsuit Accuses Dialysis Company DaVita Inc. of Overbilling Medicare and… [read post]
11 Feb 2013, 6:44 pm by FDABlog HPM
District Court for the District of Columbia ruled against FDA in a challenge brought by Watson Laboratories, Inc. [read post]